Resolve salt and formulation differences
FDA's safety discussion names selank acetate (TP-7). A report for an unspecified Selank material does not by itself resolve the salt and finished-formulation questions.
Documentation to request
Request the exact identity and salt, plus format-specific content and labeling for the vial or spray being compared.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.